BIOCEPT INC Quarterly Interest Expense in USD from Q1 2013 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Biocept Inc quarterly/annual Interest Expense history and growth rate from Q1 2013 to Q2 2023.
  • Biocept Inc Interest Expense for the quarter ending June 30, 2023 was $50K, a 67.7% decline year-over-year.
  • Biocept Inc annual Interest Expense for 2022 was $316K, a 8.97% increase from 2021.
  • Biocept Inc annual Interest Expense for 2021 was $290K, a 22.9% increase from 2020.
  • Biocept Inc annual Interest Expense for 2020 was $236K, a 5.59% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $50K -$105K -67.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $46K -$15K -24.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q2 2022 $361K $155K +$75.3K +94.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $286K $61K -$4K -6.15% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $290K $70.8K +$6.7K +10.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 $283K $74.5K +$15K +25.1% Jul 1, 2021 Sep 30, 2021 10-Q/A 2022-02-15
Q2 2021 $268K $79.7K +$24K +43.2% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $244K $65K +$8.3K +14.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 $236K $64.1K +$1.7K +2.73% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-05
Q3 2020 $234K $59.5K -$2.48K -4% Jul 1, 2020 Sep 30, 2020 10-Q/A 2022-02-15
Q2 2020 $237K $55.6K -$7.93K -12.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $245K $56.7K -$5.28K -8.52% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $250K $62.4K -$17.9K -22.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $268K $62K -$1.74K -2.72% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $270K $63.6K -$20.7K -24.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $290K $62K -$20.7K -25% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $311K $80.3K -$17.2K -17.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 $328K $63.8K -$24.5K -27.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $353K $84.2K -$130K -60.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $483K $82.7K +$148 +0.18% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $483K $97.5K -$35.4K -26.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 $518K $88.3K -$66.6K -43% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $585K $214K +$115K +115% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $470K $82.5K -$55.9K -40.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $526K $133K -$12.5K -8.58% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-28
Q3 2016 $538K $155K -$20.7K -11.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $559K $99.7K -$69.8K -41.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $629K $138K -$10.8K -7.21% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $640K $145K -$4.32K -2.89% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-28
Q3 2015 $644K $176K +$24.1K +15.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $620K $169K +$75.4K +80.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $544K $149K -$1.25M -89.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $1.79M $150K -$485K -76.4% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-10
Q3 2014 $2.28M $151K -$306K -66.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $2.58M $94.1K -$416K -81.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 $3M $1.39M +$927K +198% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 $2.07M $635K Oct 1, 2013 Dec 31, 2013 10-K 2015-03-11
Q3 2013 $457K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $510K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 $468K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.